Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2021 Sep 7;11:759578. doi: 10.3389/fonc.2021.759578

Retraction: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways

Frontiers Editorial Office1,*
PMCID: PMC8453336  PMID: 34557421

The Journal and Authors retract the 12 March 2021 article cited above for the following reasons provided by the Authors:

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES